VA awards $1.45M contract for Chemistry/Immunochemistry Laboratory to Roche Diagnostics
Contract Overview
Contract Amount: $1,450,682 ($1.5M)
Contractor: Roche Diagnostics Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2023-10-01
End Date: 2026-04-10
Contract Duration: 922 days
Daily Burn Rate: $1.6K/day
Competition Type: FULL AND OPEN COMPETITION
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: CHEMISTRY/IMMUNOCHEMISTRY LABORATORY FOR PR.
Place of Performance
Location: INDIANAPOLIS, MARION County, INDIANA, 46256
State: Indiana Government Spending
Plain-Language Summary
Department of Veterans Affairs obligated $1.5 million to ROCHE DIAGNOSTICS CORPORATION for work described as: CHEMISTRY/IMMUNOCHEMISTRY LABORATORY FOR PR. Key points: 1. Contract awarded to a single, established supplier. 2. Potential for higher costs due to limited competition. 3. Long-term contract duration may impact price competitiveness. 4. Spending aligns with analytical laboratory instrument manufacturing sector.
Value Assessment
Rating: fair
The contract value of $1.45M over approximately 2.5 years suggests a moderate annual spend. Benchmarking against similar laboratory instrument contracts is difficult without specific unit details, but the price appears reasonable for specialized equipment and services.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating that multiple vendors had the opportunity to bid. However, the award to a single vendor, Roche Diagnostics, suggests they were the most competitive or offered a unique solution.
Taxpayer Impact: The use of full and open competition aims to secure the best value for taxpayers. The final price reflects the competitive landscape at the time of award.
Public Impact
Ensures continued access to essential laboratory testing for veterans. Supports diagnostic capabilities within the VA healthcare system. Potential impact on smaller, competing laboratory equipment providers.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Limited vendor choice post-award
- Potential for price creep over contract duration
Positive Signals
- Awarded under full and open competition
- Supports critical healthcare services
Sector Analysis
This contract falls within the Analytical Laboratory Instrument Manufacturing sector, which involves specialized equipment for medical diagnostics. Spending benchmarks for such contracts vary widely based on technology and scope, but this award appears within a typical range for a multi-year, comprehensive laboratory solution.
Small Business Impact
While the contract was awarded under full and open competition, the award went to a large corporation, Roche Diagnostics. There is no explicit indication of small business participation in this specific award, suggesting limited direct benefit to small businesses in this instance.
Oversight & Accountability
The Department of Veterans Affairs is responsible for overseeing this contract. Standard procurement regulations and contract management practices should ensure accountability and adherence to terms, but specific oversight details are not provided.
Related Government Programs
- Analytical Laboratory Instrument Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Sole awardee despite full and open competition
- Lack of detailed cost breakdown
- Absence of specified performance metrics
- Long contract duration
Tags
analytical-laboratory-instrument-manufac, department-of-veterans-affairs, in, bpa-call, 1m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $1.5 million to ROCHE DIAGNOSTICS CORPORATION. CHEMISTRY/IMMUNOCHEMISTRY LABORATORY FOR PR.
Who is the contractor on this award?
The obligated recipient is ROCHE DIAGNOSTICS CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $1.5 million.
What is the period of performance?
Start: 2023-10-01. End: 2026-04-10.
What is the specific breakdown of costs for instruments, reagents, and maintenance within this contract?
The provided data does not detail the cost breakdown. A full analysis would require access to the contract's line-item details to understand the allocation between capital equipment, consumables, and service agreements. This information is crucial for assessing value and identifying potential areas for cost optimization.
Were there any performance metrics or service level agreements included in the contract to ensure quality and timeliness of laboratory services?
The data does not specify performance metrics or SLAs. Effective oversight would typically include such clauses to guarantee the quality, accuracy, and turnaround time of laboratory results. The absence of this information raises a potential risk regarding service quality assurance.
How does the annual cost of this contract compare to the VA's previous spending on similar laboratory services or equipment?
A comparative analysis against historical VA spending on comparable services or equipment is not possible with the given data. Benchmarking against prior contracts or industry averages for similar capabilities would be necessary to determine if this award represents cost savings or an increase.
Industry Classification
NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing
Product/Service Code: INSTRUMENTS AND LABORATORY EQPT
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Roche Holding AG
Address: 9115 HAGUE RD, INDIANAPOLIS, IN, 46256
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $1,450,682
Exercised Options: $1,450,682
Current Obligation: $1,450,682
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: 36C24823A0029
IDV Type: BPA
Timeline
Start Date: 2023-10-01
Current End Date: 2026-04-10
Potential End Date: 2026-04-10 00:00:00
Last Modified: 2026-04-10
More Contracts from Roche Diagnostics Corporation
- THE Purpose of This Contract IS to Procure the Procurement of Over the Counter (OTC) Covid-19 Tests — $90.6M (Department of Health and Human Services)
- Cost PER Test — $13.5M (Department of Veterans Affairs)
- CPT — $5.5M (Department of Veterans Affairs)
- Chemistry-Immunochemistry CPR — $4.6M (Department of Veterans Affairs)
- FY22 CPT Chemistry Analyzer — $4.2M (Department of Health and Human Services)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)